Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 24 | 2023 | 10900 | 1.640 |
Why?
|
Ramipril | 8 | 2023 | 95 | 0.880 |
Why?
|
Myocardial Infarction | 12 | 2024 | 11727 | 0.880 |
Why?
|
Angiotensin Receptor Antagonists | 8 | 2023 | 924 | 0.660 |
Why?
|
Stroke Volume | 19 | 2023 | 5007 | 0.650 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 6 | 2022 | 1518 | 0.550 |
Why?
|
Mercury Poisoning | 1 | 2015 | 33 | 0.520 |
Why?
|
Parenteral Nutrition Solutions | 1 | 2015 | 27 | 0.520 |
Why?
|
Biphenyl Compounds | 7 | 2023 | 913 | 0.500 |
Why?
|
Drug Combinations | 8 | 2023 | 1959 | 0.480 |
Why?
|
Tetrazoles | 8 | 2023 | 835 | 0.480 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 906 | 0.470 |
Why?
|
Mercury | 1 | 2015 | 285 | 0.430 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1440 | 0.410 |
Why?
|
Organ Transplantation | 1 | 2021 | 1139 | 0.390 |
Why?
|
Pulmonary Edema | 2 | 2024 | 414 | 0.370 |
Why?
|
Parenteral Nutrition | 1 | 2015 | 650 | 0.370 |
Why?
|
Ventricular Function, Left | 8 | 2023 | 3670 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.340 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2024 | 2073 | 0.340 |
Why?
|
Critical Care | 1 | 2021 | 2647 | 0.320 |
Why?
|
Neprilysin | 4 | 2022 | 439 | 0.300 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 1965 | 0.300 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7913 | 0.280 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2023 | 1573 | 0.240 |
Why?
|
Prognosis | 7 | 2023 | 29063 | 0.230 |
Why?
|
Prospective Studies | 10 | 2023 | 53288 | 0.220 |
Why?
|
Hyperkalemia | 1 | 2023 | 218 | 0.200 |
Why?
|
Hospitalization | 6 | 2023 | 10262 | 0.190 |
Why?
|
Benzhydryl Compounds | 2 | 2023 | 845 | 0.190 |
Why?
|
Hospital Mortality | 4 | 2021 | 5317 | 0.190 |
Why?
|
Hypotension | 2 | 2023 | 884 | 0.180 |
Why?
|
Pulmonary Embolism | 2 | 2022 | 2376 | 0.180 |
Why?
|
Peptide Fragments | 2 | 2023 | 5097 | 0.170 |
Why?
|
Receptors, Angiotensin | 3 | 2022 | 142 | 0.160 |
Why?
|
Humans | 35 | 2024 | 744343 | 0.150 |
Why?
|
Troponin I | 1 | 2021 | 619 | 0.140 |
Why?
|
Troponin T | 1 | 2021 | 754 | 0.140 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 759 | 0.130 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5034 | 0.120 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 32 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1506 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 251 | 0.110 |
Why?
|
Comorbidity | 3 | 2023 | 10388 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2022 | 2266 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2046 | 0.100 |
Why?
|
Angiotensins | 2 | 2022 | 151 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1912 | 0.100 |
Why?
|
Female | 14 | 2023 | 380194 | 0.100 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2795 | 0.090 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2518 | 0.090 |
Why?
|
Oligodendroglia | 1 | 2014 | 517 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
Glucosides | 2 | 2023 | 451 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2208 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5756 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2788 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2014 | 851 | 0.070 |
Why?
|
Infant, Premature | 1 | 2015 | 2044 | 0.070 |
Why?
|
Kidney | 1 | 2020 | 7186 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5751 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8089 | 0.060 |
Why?
|
Kansas | 1 | 2023 | 39 | 0.060 |
Why?
|
Europe, Eastern | 1 | 2023 | 75 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.060 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2161 | 0.060 |
Why?
|
Aged | 7 | 2023 | 163280 | 0.050 |
Why?
|
Male | 10 | 2023 | 350118 | 0.050 |
Why?
|
Furosemide | 1 | 2022 | 167 | 0.050 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 135 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 282 | 0.050 |
Why?
|
Pulmonary Circulation | 1 | 2024 | 739 | 0.050 |
Why?
|
Risk Factors | 3 | 2022 | 72290 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
Diuretics | 1 | 2022 | 592 | 0.040 |
Why?
|
Self Efficacy | 1 | 2023 | 616 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 29144 | 0.040 |
Why?
|
Middle Aged | 6 | 2023 | 213383 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 12354 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2022 | 859 | 0.040 |
Why?
|
Europe | 1 | 2023 | 3339 | 0.030 |
Why?
|
United States | 2 | 2021 | 69872 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 25625 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 63114 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1177 | 0.030 |
Why?
|
Infant | 1 | 2015 | 35136 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2585 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1786 | 0.030 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4217 | 0.030 |
Why?
|
Acute Disease | 1 | 2022 | 7149 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 379 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2531 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3461 | 0.020 |
Why?
|
Adult | 2 | 2021 | 214055 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4034 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 5102 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1114 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12026 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 57776 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9856 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7659 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3462 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2014 | 3586 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4462 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Glioma | 1 | 2014 | 3401 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14557 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10481 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8428 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11483 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15165 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 21827 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2014 | 8863 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81183 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_